GeneFerm Biotechnology Co

GeneFerm Biotechnology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co (1796.TWO) as of Oct 17, 2026 is 46.04 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -35.49 M TWD — a change of -229.72% (higher).

EBITDA

46.04 MTWD

YoY

-229.72%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co is 2025 46.04 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co was 2024 -35.49 M TWD. It decreases by -229.72% higher compared to the previous year.

The GeneFerm Biotechnology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
9.82 M TWD
Jan 1, 2019
-23.38 M TWD
Jan 1, 2020
17.52 M TWD
Jan 1, 2021
79.15 M TWD
Jan 1, 2022
113.31 M TWD
Jan 1, 2023
157.18 M TWD
Jan 1, 2024
-35.49 M TWD
Jan 1, 2025
46.04 M TWD
The GeneFerm Biotechnology Co EBITDA history
YEAREBITDAYoY
46.04 MTWD-229.72%
-35.49 MTWD-122.58%
157.18 MTWD+38.71%
113.31 MTWD+43.16%
79.15 MTWD+351.80%
17.52 MTWD-174.94%
-23.38 MTWD-338.04%
9.82 MTWD-72.86%
36.19 MTWD-68.94%
116.51 MTWD+112.00%
54.96 MTWD-396.49%
-18.54 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Consumer Staples sector and the Consumer products industry. It went public on July 26, 2016, with the ticker symbol 1796.TWO and ISIN TW0001796001. The company focuses on the manufacture and sale of health food and dietary supplements. Its product portfolio includes fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrates. GeneFerm also offers related manufacturing services, as well as health food design, research, and development services. The company's headquarters are located in Tainan, Taiwan, and it maintains a website at https://www.geneferm.com/. As a publicly traded entity, GeneFerm Biotechnology Co Ltd is listed on the Taiwan Stock Exchange, providing investors with access to its financial performance and corporate activities. The company's operations are centered around the development and production of health-focused food and supplement products, emphasizing natural and fermented ingredients. Its services extend beyond product manufacturing to include design, R&D, and manufacturing support for health food solutions. The firm has been active in the market since its IPO in 2016, contributing to the consumer staples sector with its specialized health food offerings. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co is 46.04 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co changed from -35.49 M TWD to 46.04 M TWD, representing a -229.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s GeneFerm Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — GeneFerm Biotechnology Co

All Key Metrics — GeneFerm Biotechnology Co